Compare Hims and Hers Health Inc (HIMS) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Nuscale Power Corporation — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Nuscale Power Corporation trades at $7.2 (market cap $3.00B). The key difference: Hims and Hers Health Inc is far larger — about 2.2× Nuscale Power Corporation's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Nuscale Power Corporation for 29 Days on average.
| HIMS | SMR | |
|---|---|---|
Market Cap | $6.55B | $3.00B |
Volume | 14,842,814 | 43,143,109 |
Sector | Health | Industrials |
52-Week High | $62.76 | $53.43 |
52-Week Low | $14.52 | $7.20 |
Typical Hold Time | 21 Days | 29 Days |
Enterprise Value | $7.25B | $1.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.
The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.
NuScale Power (SMR) trades at $7.32, down 4.56% with bearish technical signals. The company shows concerning fundamentals with negative net income margin of -3,888.7% and declining revenue from $31.48M in 2025 to $11M in 2026. Despite operating cash burn, financing activities provided $1.31B in 2025. Analyst consensus is mixed with 50% buy ratings but ongoing SEC investigation concerns.
The stock faces significant execution risk in commercializing SMR technology amid cash burn and competitive pressure. Upside exists if NuScale achieves commercialization milestones, with analyst targets up to $16. However, current financial performance and negative margins present substantial risk for investors seeking near-term returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
